GERI-BP-001

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameGERI-BP-001

Drug Alias NameGERI-BP-001

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsArteriosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesWyeth BioPharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesWyeth BioPharma

Active IndicationsN/A

Inactive IndicationsArteriosclerosis

ATC CodeN/A